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Abstract
In the UK, treatment recommendations for patients with cancer are routinely made by multidisciplinary teams in weekly meetings.
However, their performance is variable.
The aim of this study was to explore the underlying structure of multidisciplinary decision-making process, and examine how it
relates to team ability to reach a decision.
This is a cross-sectional observational study consisting of 1045 patient reviews across 4 multidisciplinary cancer teams from
teaching and community hospitals in London, UK, from 2010 to 2014. Meetings were chaired by surgeons.
We used a validated observational instrument (Metric for the Observation of Decision-making in Cancer Multidisciplinary Meetings)
consisting of 13 items to assess the decision-making process of each patient discussion. Rated on a 5-point scale, the items
measured quality of presented patient information, and contributions to review by individual disciplines. A dichotomous outcome
(yes/no) measured team ability to reach a decision. Ratings were submitted to Exploratory Factor Analysis and regression analysis.
The exploratory factor analysis produced 4 factors, labeled “Holistic and Clinical inputs” (patient views, psychosocial aspects,
patient history, comorbidities, oncologists’, nurses’, and surgeons’ inputs), “Radiology” (radiology results, radiologists’ inputs),
“Pathology” (pathology results, pathologists’ inputs), and “Meeting Management” (meeting chairs’ and coordinators’ inputs). A
negative cross-loading was observed from surgeons’ input on the fourth factor with a follow-up analysis showing negative correlation
(r=0.19, P<0.001). In logistic regression, all 4 factors predicted team ability to reach a decision (P<0.001).
Hawthorne effect is the main limitation of the study.
The decision-making process in cancer meetings is driven by 4 underlying factors representing the complete patient proﬁle and
contributions to case review by all core disciplines. Evidence of dual-task interference was observed in relation to the meeting chairs’
input and their corresponding surgical input into case reviews.
Abbreviations:MDM =Multidisciplinary teammeeting, MDT = Multidisciplinary team, MDT-MODe = Metric for the Observation of
Decision-making in cancer Multidisciplinary Teams, MTB = Multidisciplinary tumor board
Keywords: database analysis, group decision-making, national health services, oncology, performance measurement
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1. Introduction
1.1. Background
As a mandatory part of cancer care services in the UK,
multidisciplinary team meetings (MDMs) comprise of diverse
range of professionals—including surgeons, oncologists, radiol-
ogists, specialist cancer nurses, and pathologists.[1] Their purpose
is to provide expert reviews of patient cases and formulate
treatment recommendations, thus improving patient experience
and ensuring well-coordinated delivery of safe, high-quality care.
Although cancer guidelines support a multidisciplinary ap-
proach,[1] the empirical evidence of its effectiveness in terms of
patient survival remains unclear,[2] and team performance across
tumors is variable.[3] One pattern that keeps reemerging in recent
studies is the skewed contribution to case reviews toward senior
physicians and biomedical aspects of the disease; in contrast,
cancer nurses’ input, patients’ comorbidities, and their psycho-
social circumstances are underrepresented.[4–6] In line with this
pattern, evidence from patient experience studies shows
suboptimal experience of care often because of psychosocial
circumstances not being adequately addressed and a “holistic”
view of the patient not being considered by the healthcare
providers.[7–8] Moreover, multidisciplinary team (MDT) mem-
bers highlighted the importance of having a complete patient
proﬁle, as well as all participating disciplines in attendance, for
effective decision-making.[9] Improving MDT working therefore
is complex although highly important with the cancer incidence
and costs of care being predicted to rise,[10–11] whereas the
signiﬁcant ﬁnancial pressures on the healthcare remain.[12]
The National Cancer Action Team in England identiﬁed core
domains essential for effective MDT working, including the team
(e.g., attendance, team culture, training), infrastructure for
meetings, organization and logistics, team governance, and
ﬁnally, clinical decision-making process[13]—the latter being the
primary focus of this article. Time pressures, cancer specialist
nonattendance, lack of necessary information, poor consider-
ation of patient wishes, and comorbidities,[9] as well as poor team
climate[14] have all been reported to have negative impact on the
team in MDMs. Correspondingly, the functional perspective of
group decision-making posits that the internal factors coming
from within the group (member composition, group size,
interactions, culture, beliefs, attitudes, history among group
members) and the external circumstances (time pressure,
workload) both impact the way groups perform, with the group
size and diversity being positively related to performance and
range of abilities, and negatively related to effective processes and
equality of participation.[15–16] This pattern is also evident in
cancer MDMs.
More research is therefore needed to understand how the
process of decision-making is currently structured in MDMs—
whether this is at the service of promoting effective decision-
making, and how it impacts team outcomes. For instance,
evidence from MDMs shows that the chairing of the meeting
tends to be led by one of the contributing disciplines, and
predominantly by more senior surgical members of the team.[17]
This, however, may not be an optimal set up. Evidence from
cognitive psychology shows that the competition in dual-task
performance (in the case of the MDM, chairing while contribut-
ing to case reviews) is detrimental to one or both tasks that are
being undertaken simultaneously,[18] whereas evidence from
patient safety and functional perspective shows that communi-
cation between healthcare professionals can be negatively
affected by a steep authority gradient, which can emerge when
a senior clinician chairs a MDM.[15,19–22] The latter ﬁnding is
further supported by early social science research,[23–24] the
results of which were subsequently used to improve team
effectiveness in many industries, including aviation.[25]
1.2. Objectives
Our primary objectives were to examine the underlying structure
of team decision-making during case reviews, investigating how
the different elements of the decision process cluster together and
to understand how it affects team outcome, that is, the team
ability to reach a treatment decision/plan.
To achieve this, we conducted a series of analyses on a large
multtumor database that was compiled using a novel validated
instrument for the observational assessment of decision-making
in cancer MDMs—namely, Metric for the Observation of
Decision-Making in cancer MDTs, also known as, MDT-
MODe.[4] Although tools have been developed to evaluate
various aspects of MDM performance, to our knowledge, this is
the only instrument designed speciﬁcally to measure the process
of multidisciplinary decision-making.
2. Methods
2.1. Study design
This is a cross-sectional observational study that represents a
secondary analysis of the data. Originally, the data were acquired
through our center’s ongoing research program in evaluating
and improving MDT working across different tumors and was
used to descriptively assess decision-making process within
cancer teams using MDT-MODe. Since this was a secondary
analysis, ethical approval was not required; however, at the
time of data collection, ethical approvals were in place for all
prospective evaluations.
2.2. Setting
The study recruited 4 independent cancer teams between 2010
and 2014 from 1 teaching university hospital (lung cancer team)
and 3 large community hospitals (breast, colorectal, and urology
cancer teams) of the London (UK) metropolitan area. Observa-
tions were conducted in real-time over 10 consecutive meetings
within each MDT by 4 trained surgeon evaluators (breast=SA,
colorectal=SMS, lung=SS, urological=BWL) who assessed the
cancer team that corresponded to their clinical specialty.
Reliability was assessed by having 4 surgeon evaluators score
a subset of cases in pairs. The evaluators were not members of the
MDT they were assessing.
2.3. Participants and study size
Participants were 4 multidisciplinary cancer teams with a total of
52 members, and an overall of 1045 individual case reviews
discussed over a period of 10 weekly meetings respectively.
Eligibility criteria for the study were deﬁned as multidisciplinary
cancer teams from the UK National Health Service (NHS) that
represent 4 most common types of cancer (breast, lung urological
and colorectal) and discuss patients referred to them for care
planning recommendations. An availability sampling approach
was used to identify teams that met eligibility criteria, whereas a
set number of meetings within each team determined the number
of case discussions for analysis.
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2.4. Variables and measurements
Case reviews within each meeting and across all 4 cancer teams
were assessed in the samemanner by assessors whowere clinicians
specialized in the cancer they observed, and trained beforehand in
the use of the MDT-MODe, a quantitative observational assess-
ment tool (Fig. 1).[4] Training in the use of the tool is essential to be
able to use it—this is a general principle for instruments assessing
human factors in clinical environments, such that the evaluations
produced have a degree of accuracy and can be meaningfully
used.[29] The tool has been validated, and previously used to assess
various cancer MDTs.[26–28] The instrument allows a trained
evaluator (using the form shown in Fig. 1) to provide for each case
review carried out by the MDT a standardized score on a 1 to 5
behaviorally anchored scale of the following variables in real-time:
1. Quality of information presented at theMDM as measured by
6 variables, namely, patient history, radiology results,
pathology results, patient psychosocial aspects (i.e., psycho-
logical and social factors, including mental health difﬁculties,
socioeconomic issues, and personal circumstances), comor-
bidity (i.e., medical history and performance status), and
patients’ wishes or opinions regarding treatment.
2. Quality of multidisciplinary case review as measured by the
contributions of 7 core disciplines, namely, chairperson,
surgeon, oncologist, nurse, radiologist, histopathologist, and
coordinator. Quality of MDT chairing is evaluated based on
national guidelines for England,[13] which outline the core
competencies that are important for chairing: meeting manage-
ment, listening and communication, interpersonal relations,
managing disruptive personalities and conﬂict, negotiations,
facilitating effective consensual decision-making, and time
management. Other MDT-members are rated on the basis of
their clear contribution of their specialty to the case review.
The outcome measure is a dichotomous variable (yes/no) that
allows recording whether or not a clear treatment decision was
reached for a patient (Fig. 1). In the statistical analysis, type of
tumor was considered as a potential confounder. No other
variables were included in the ﬁnal model.
2.5. Bias
Efforts were made to address potential biases in the study. We
addressed observer bias and had ensured reliability of evalua-
tions on the MDT-MODe by having a subset of cases scored by
the 4 clinical evaluators in pairs who were all trained and
experienced in the use of the instrument. During data collection,
each evaluator was blind to the other evaluators’ observations.
All data were collated for analysis by a separate researcher (TS).
We are aware that Hawthorne effect, that is, teams changing
their usual behavior owing to being observed, is a natural
limitation to observational studies, and in our study, MDT
members were aware that they were being observed. In England,
MDMs are commonly attended by visiting clinicians, students,
researchers, clinical auditors as well as interns and residents on
rotation. This means that in practice being “observed” in
some way or other is rather common within these teams—and
hence the presence of our study’s clinical observers would not
be overwhelming to the teams. We therefore believe that the
presence of the observer, discreetly positioned at the back of
the MDT meeting, would have had minimal impact on the
proceedings of the meetings, particularly as the study occurred
over a number of weeks (and thus allowed for acclimatization of
the teams to the observers), and the evaluators were clinicians
(specialized in the cancer that they observed), the presence of
whom within the MDT is natural. We return to the Hawthorne
effect issue in the discussion.
Informaon Contribuon OUTCOME
# Site Point Hx X-ray Path Psy/soc Co-
morbid
Paent 
view
Chair Surg   Phys Oncolo Nurse Radiolo Histopath Y/D/N Free text
1
2
History 5 Fluent, comprehensive case history. Psycho-
social
5 Comprehensive ﬁrst-hand knowledge of paents’ personal circumstances, 
social and psychological issues.
3 Paral case history. 3 Vague ﬁrst-hand knowledge, or good second-hand knowledge of personal 
circumstances, social and psychological issues.
1 No paent case history. 1 No knowledge of personal circumstances, social and psychological issues
x-ray 5 Radiological images. Co-
morbidity
5 Comprehensive ﬁrst-hand knowledge of paents’ past medical history and 
performance status.
3 Radiological informaon from a report/ account. 3 Vague ﬁrst-hand knowledge, or good second-hand knowledge of past 
medical history or performance status.
1 No provision of radiological informaon. 1 No knowledge of past medical history or performance status.
Pathology 5 Histopathological informaon explained with slides/pictures. Paent’s 
views
5 Comprehensive ﬁrst-hand knowledge of paents’ wishes or opinions 
regarding treatment.
3 Histopathological informaon from a report/account. 3 Vague ﬁrst-hand knowledge, or good second-hand knowledge of paent’s 
wishes or opinions regarding treatment.
1 No provision of Histopathological informaon. 1 No knowledge of paent’s wishes or opinions regarding treatment.
Chair 5 Good leadership enhanced team discussion and decision making. Members 5 Clear contribuon of speciality.
3 Leadership neither enhanced nor impeded team discussion and decision making. 3 Contribuon inarculate or vague.
1 Poor/inadequate leadership impeded team discussion and decision making. 1 No contribuon.
Point Pre Rx Pre-treatment. Decision Y Clear decision about treatment(s) to be oﬀered.
Post Rx Post treatment. D Decision to defer to next MDT.
R Recurrence/ surveillance. N No decision/decision unclear.
Figure 1. Metric for the observation of decision-making used to assess case discussions in cancer multidisciplinary team meetings.[4]
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2.6. Statistical methods
Intra-class coefﬁcient (ICC) analysis was initially used to assess
reliability of evaluations. ICCs can range between 0 and 1, with
higher values indicating better agreement between evaluators. A
recent expert consensus has deﬁned a reliability coefﬁcient of
0.70 as a minimum value for data to be used for research
purposes.[29]
Exploratory factor analysis (EFA) and logistic regression were
subsequently carried out to assess the underlying structure of
decision-making process during case reviews. The variables that
were included in the EFA were individual items of information
and specialist contribution quality as assessed by MDT-MODe.
EFA extracted factors (using a regression method) were then
entered in a multiple logistic regression model as predictor
variables to assess their relation to the outcome, that is, team
ability to reach a decision with 0 denoting no decision reached,
and 1 decision reached. Variable representing individual teams
within the sample (i.e., breast, lung, urology, and colorectal
cancer teams) was also entered in the regression model as a
covariate to examine its’ potential confounding effect. Signiﬁ-
cance was set at P<0.05.
All analyses were carried out using SPSS
®
version 20.0 software
(SPSS Inc, Chicago, IL), and there were no missing data.
3. Results
3.1. Descriptive analysis
The descriptive data for meeting characteristics are shown in
Table 1. Representing the most common cancers in the UK, the
sample consisted of overall 1045 case discussions across 4 teams
within a NHS setting. The composition of health care personnel
in MDTs did not signiﬁcantly vary across groups. All teams
consisted of a coordinator (administrator), chair and senior
(Consultant/Attending level) cancer specialists, that is, surgeons,
oncologists, radiologists, pathologists, and cancer nurses, with
the exception of lung, wherein a chest physician was also present.
Table 2 shows detailed descriptive data for the MDT-MODe
variables across all 4 cancer teams.
3.2. Reliability of evaluations: ICCs
Interevaluator agreement was assessed via ICCs on a randomly
selected subset of the observed cases (N=273, 26% of the total
cohort). High reliability was obtained across all tumors: breast
(median ICC=0.92 [range 0.27–1.00]); colorectal (median
ICC=0.83 [range 0.69–0.96]); lung (median ICC=0.86 [range
0.71–0.99]); and urological (median ICC=0.71 [range
0.31–0.87]). This ﬁnding means that all 4 surgeon evaluators
were consistent in their use of theMDT-MODe instrument across
evaluated cases. The full intrarater reliability matrix for all
individual items across all 4 cancer teams is provided as the
Supplementary data table.
3.3. Anatomy of decision-making: EFA
To assess the underlying structure of the decision-making process
in MDM, an EFA was applied to the 13 MDT-MODe items. All
the criteria for factor analysis were met—sample size was
adequate (KMO=0.67), and the variables sufﬁciently intercor-
related, (X2(78)=3329.18, P<0.001), with none of the
coefﬁcients being particularly large or zero. Based on Kaiser
criterion (eigen values for the ﬁrst 6 factors were 2.99, 2.11, 1.34,
1.19, 0.95, 0.89), Scree plot, and clinical considerations, 4 factors
were extracted and rotated to simple structure via the oblique
Promax algorithm with the Kappa parameter set to 4. Oblique
rotation was chosen because it is considered a more accurate,
reproducible solution, allowing the factors to correlate.[30] The 4
factors together explained 59% of the variance in the 13 MDT-
MODe items. All items were well represented in the extracted
4 factors, with an average communality of 0.59. The best
represented items were radiologists’ input, h2=0.84, patholo-
gists’ input, h2=0.83, radiological information, h2=0.83, and
pathological information, h2=0.84, whereas the least well-
represented item was chair’s input h2=0.39.
Table 3 presents the resulting factor pattern matrix. The
highest-loading variables on the ﬁrst factor were patient views on
the treatment options (0.70), oncologists’ input into case
discussion (0.67), nurses’ input into case discussion (0.65), and
patient psychosocial aspects (0.60). Accordingly, this factor was
labeled “Holistic and Clinical inputs,” representing patients’
holistic and clinical needs. The highest-loading variables on the
second factor were patient radiological information presented to
the team (0.91) and radiologists’ input into case discussion (0.93).
Accordingly, this factor was labeled ‘Radiology’, representing
radiological proﬁle of patients’ disease. The highest-loading
variables on the third factor were patient pathological informa-
tion presented to the team (0.90) and pathologists’ input into case
discussion (0.96). Accordingly, this factor was labeled “Patholo-
gy,” representing pathological proﬁle of patients’ disease. The
highest-loading variables on the fourth factor were coordinator’s
(0.68) and meeting chair’s (0.61) inputs into case discussion.
Accordingly, this factor was labeled “Meeting Management,”
representing the management of case discussions within the
meeting (chair), and general management and organization of
cases for discussion (coordinator). Figure 2 shows a graphical
representation of the 4-factor model.
As evident from Table 3, 1 variable, namely, surgeons’ input,
cross-loads positively (0.43) on “Holistic and Clinical inputs, ”
and negatively (0.41) on “Meeting Management.” Since
Table 1
Descriptive data of multidisciplinary team meetings observed.
Meeting characteristics Outcome
Cancer
team
Type of
hospital
No. of
meetings
observed
No. of core
members
present
No. of
cases
discussed
Average no. of
cases discussed
per meeting
No. of cases
with a decision
reached (%)
Breast Community 10 13 224 22 203 (91%)
Colorectal Community 10 11 185 19 161 (87%)
Lung Teaching 10 13 254 26 218 (86%)
Urology Community 10 15 382 38 319 (84%)
Total — 40 52 1045 26 900 (86%)
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surgeons in our sample also chaired the meetings, thus
undertaking 2 tasks simultaneously, we further explored the
relationship between the 2 using Spearman correlational analysis.
A signiﬁcant negative association was found between surgeons’
and chairs’ inputs to case reviews (r=0.19, P<0.01), indicating
that as the surgeons’ inputs increased, the chairs’ inputs
decreased. In contrast, the relationship between surgeons’ and
coordinators’ inputs was nonsigniﬁcant (r=0.04, P>0.05). It
is reasonable to conclude, therefore, that the negative cross-
loading in the EFA is driven by the negative surgeon–chair
association. This ﬁnding is in line with the theory of dual task
interference,[18] as discussed later.
Factor inter-correlations were generally low at r=0.26 or less.
The full factor inter-correlation matrix is available upon request
from the corresponding author.
3.4. Predictors of outcome: logistic regression
To explore the relation between the 4 factors and the outcome
variable, namely, the team ability to reach a treatment decision on
ﬁrst case review, we performed a multiple logistic regression
analysis. After adjusting for tumor type, all 4 factors, including
“Holistic and Clinical inputs” (Wald(1)=17.88, P<0.001),
“Radiology” (Wald(1)=12.01, P<0.001), “Pathology” (Wald
(1)=23.22, P<0.001), and “Meeting Management” (Wald(1)=
12.30, P<0.001) were signiﬁcantly related to the treatment
decision. To facilitate interpretation, we converted the odds
ratios into probability percentages, using the following formula:
odds/(odds+1)100=probability %.[31] We found that “Ho-
listic and Clinical” inputs, “Radiology,” and “Pathology”
contributed the most to the probability of the team to reach a
treatment decision for a patient (Table 4).
Table 3
Rotated factor loadings based on exploratory factor analysis of 13 items of the MDT-MODe.
Extracted factors
1 2 3 4
MDT-MODe variables Holistic and clinical inputs Radiology Pathology Meeting Management
Information quality
Patient views 0.70 0.04 0.06 0.00
Psychosocial information 0.60 0.01 0.02 0.34
Patient history 0.51 0.27 0.09 0.28
Comorbidities 0.51 0.16 0.12 0.40
Radiological information 0.06 0.91 0.02 0.12
Pathological information 0.03 0.04 0.90 0.10
Contribution quality
Oncologists’ input 0.67 0.12 0.19 0.17
Nurses’ input 0.65 0.12 0.05 0.13
Surgeons’ input 0.43 0.33 0.19 0.41∗
Radiologists’ input 0.02 0.93 0.01 0.11
Pathologists’ input 0.16 0.04 0.96 0.11
Coordinator’s input 0.24 0.15 0.10 0.68
Chair’s input 0.10 0.14 0.07 0.61
Note: N=1045. MDT-MODe=Metric for the Observation of Decision-making in cancer Multidisciplinary Teams.
∗
Item negatively cross-loading.
Table 2
Descriptive data of the scores on the MDT-MODe across cancer teams.
Cancer Teams
Lung (n=254) Breast (n=225) Colorectal (n=185) Urology (n=382) Overall (N=1045)
MDT-MODe items M (SD) M (SD) M (SD) M (SD) M (SD)
Information Patient history 3.50 (0.88) 4.43 (0.76) 4.02 (0.84) 3.34 (0.98) 3.73 (0.97)
X-ray 4.69 (0.99) 4.67 (0.81) 4.04 (1.13) 2.59 (1.66) 3.80 (1.58)
Pathology 1.62 (1.32) 3.08 (1.69) 2.55 (1.75) 2.73 (1.21) 2.51 (1.44)
Psycho-social 2.18 (1.43) 2.44 (1.02) 2.34 (1.34) 1.59 (1.14) 2.05 (1.28)
Comorbidity 2.28 (1.33) 2.60 (1.05) 3.06 (1.23) 1.59 (1.14) 2.24 (1.31)
Patient view 1.21 (0.74) 2.47 (1.01) 2.45 (1.33) 1.24 (0.82) 1.71 (1.13)
Contribution Chair 3.88 (1.32) 2.77 (1.54) 3.9 (1) 3.53 (0.68) 3.42 (1.08)
Surgeon 1.63 (1.32) 4.23 (1.17) 3.81 (1.02) 4.27 (1.36) 3.54 (1.67)
Oncologist 2.16 (1.57) 2.69 (1.57) 3.15 (1.72) 2.09 (1.66) 2.44 (1.67)
Nurse 1.95 (1.44) 3.23 (1.00) 3.48 (1.52) 1.18 (0.67) 2.21 (1.48)
Radiologist 4.3 (1.11) 4.57 (0.92) 3.81 (1.27) 2.17 (1.76) 3.50 (1.73)
Histopathologist 1.69 (1.46) 2.13 (1.47) 2.36 (1.59) 2.07 (1.71) 2.04 (1.59)
Coordinator 1.18 (0.63) 1 2.03 (1.24) 1 1.30 (0.94)
Note: N=1045. Scores range from 1 to 5—higher the scores, better the quality of information and contribution. MDT-MODe=Metric for the Observation of Decision-making in cancer Multidisciplinary Teams,
SD=standard deviation.
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4. Discussion
4.1. Summary
The current study used multivariate statistical methods to gain a
better understanding of the anatomy of group decision-making in
cancer MDMs, and how it relates to team ability to reach
treatment recommendation. We showed that the decision-
making process in cancer MDMs is driven by 4 underlying
factors—namely, “Holistic and Clinical inputs,” “Pathology,”
“Radiology,” and “Meeting Management.” These were all
signiﬁcantly predictive of team ability to reach a treatment
decision on ﬁrst case review. The inputs of chairs (who were
surgeons in our sample) were shown to compete with their
corresponding disciplinary contributions to case reviews at the
detriment of themeetingmanagement—that is, as surgeons’ input
to case reviews increased, chair’s input decreased.
4.2. Limitations
We have used observational data with participants being aware
that they were being evaluated; hence, we cannot rule out
observer biases and the Hawthorne effect. This is a natural
limitation to all observational evaluations, and in our dataset, we
used blinded clinical evaluators (the presence of whom within a
MDT is natural) and a previously validated tool, ensuring
satisfactory inter-assessor reliability. Further, the nature of
MDT-MODe may not do justice to the complex roles of the
MDT chairperson and coordinator. This is being addressed via a
more detailed evaluation scale we are currently constructing for
chairing skills.[33] Although we have made an attempt to control
for the confounding effects of tumor type, we acknowledge that
our data are derived from different institutions and MDTs, and
that team culture including different values, beliefs. and attitudes
could inﬂuence outcomes[16]. This may have affected institutional
versus team-speciﬁc or tumor-speciﬁc factors impacting on team
decision-making. In a similar vein, conscious or unconscious
preferences for treatment may be embedded into individual
specialists’ decision-making; ideally, these should also be factored
into the decision-making “model” of the MDM as they are likely
to be a stable feature of each individual physician’s decision style.
Our study was not designed to address all of these complexities,
which would have rendered its scope unfeasible. Future work
should therefore explore a large stratiﬁed sample of cases across
hospitals and tumors to further validate our ﬁndings, and also the
intraindividual physician preferences for treatment options. Such
research would offer further understanding of how these
differences affect multidisciplinary decision-making process.
4.3. Overall interpretation
Previous research has shown that clinical decision-making
process is an essential part of effective MDT working.[13] Our
ﬁndings build on this by showing that the decision-making
process in MDMs is driven by 4 underlying factors representing
all core disciplines and the complete patient proﬁle—both
essential for the teams’ ability to reach a decision. In a recent
study, MDT members reported the importance of member
attendance, availability of patient information, considerations of
patient comorbidities, patient choices, and their current state of
health for decision-making.[9] Our article corroborates this
ﬁnding by showing that in order for the team to be able to reach a
treatment recommendation on ﬁrst case review, all participating
disciplines and the complete patient proﬁle are necessary. This is
also in line with the functional perspective of group decision-
making, which links the diversity of groups with better
performance and range of abilities, although at the expense of
effective processes and equality of participation[15]—a pattern
previously observed inMDMs.[4–6] Quality improvement efforts,
therefore, could consider focusing on the factors identiﬁed by our
study, and assessing them against team processes (e.g., social
loaﬁng, blocking, shared information bias), quality of decisions
made, and patient satisfaction.
Moreover, our ﬁnding of negative surgeon-chair’s input
association whereby the surgeons’ inputs into case review
increase as the chairs’ inputs decrease, is in line with the theory
of dual task interference, which shows that the competition in
dual-task performance is at the detriment of one or both tasks.[18]
In our sample, chairing was led by the surgical specialty that is
also required to provide input into case reviews; these are both
demanding cognitive tasks. Our study shows that providing both
Anatomy of decision-making process in cancer multidisciplinary meetings
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Figure 2. Diagram depicting the underlying components of decision-making
processes in cancer multidisciplinary team meetings.
Table 4
Logistic regression predicting treatment decision from the extracted factors of the MDT-MODe.
Unadjusted Adjusted for tumour type
95% CI for OR 95% CI for OR
Predictor B (SE) OR Lower–Upper Probability % B (SE) OR Lower–Upper Probability %
Pathology 0.57 (0.12)
∗
1.77 1.40–2.25 64% 0.59 (0.12)
∗
1.8 1.42–2.28 64%
Radiology 0.48 (0.10)
∗
1.62 1.33–1.96 62% 0.41 (0.12)
∗
1.51 1.20–1.90 60%
Holistic and clinical inputs 0.47 (0.11)
∗
1.60 1.28–1.99 62% 0.52 (0.12)
∗
1.68 1.32–2.14 63%
Meeting management 0.37 (0.10)
∗
0.70 0.56–0.85 41% 0.36 (0.10)
∗∗
0.70 0.57–0.85 41%
Constant 2.17 (0.12) 8.77 2.47 (0.32) 0.32
Note. N=1045. OR=odds ratio. -2LL=734.26. R2=0.18 (Nagelkerke). The predicted variable is treatment decision with 0 signifying no decision reached, and 1 decision reached. CI=conﬁdence interval, MDT-
MODe=Metric for the Observation of Decision-making in cancer Multidisciplinary Teams, OR=odds ratio, SE=standard error.
∗
P<0.001.
∗∗
P<0.01.
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types of input at the same time appears to be at the expense of the
coordination of the meeting. More speciﬁcally, when surgical
input into case reviews increases, the chair’s input decreases. This
is an important ﬁnding because such internal factors emanating
from within the group can affect the way the team performs.[15]
What is more, this ﬁnding can spur strategies for improving
MDM practice. For instance, assigning a chairing role to a
clinically noncontributing individual (e.g., MDT leads from other
specialties, or cancer managers), trained in team management
skills may allow the contributing members to focus solely on case
reviews and clinical decision-making. Alternatively, rotating the
chairing duty during aMDM could allow different teammembers
to chair when their direct input is not required. Also, experienced
specialist nurses could potentially take on this role.[32]
4.4. Further research
One question that was directly raised by our ﬁndings relates to
chairing and dual-task interference. Studies should look
speciﬁcally into the impact of having one of the contributing
disciplines in the MDT chair the meeting, and test alternative
options for meeting leadership that address the burden of the
chairing task to the clinical decision-making. A second question
for future research to address relates to the effects of authority
gradients on team decision-making process. Authority gradients
were ﬁrst deﬁned in aviation where it was observed that
differences in seniority and authority impede effective communi-
cation between pilots and co-pilots,[22] and the concept was
subsequently introduced to medicine in the Institute of Medicine
Report, To Err Is Human.[21] Although dual-task interference is a
valid and tested theory that should be investigated further within
MDMs, one cannot ignore that meetings are attended by >1
person from each specialty. This begs the question as to what is
the effect of the chair’s authority gradient on information
exchange and contributions to case reviews from other members
of the chair’s discipline. Additionally, this effect should also be
explored in relation to the other disciplines within the team since
nurses, for example, have traditionally lower team status. The
negative impact of authority gradients on communication
between healthcare professionals and on patient safety has been
well-documented,[15,19–22] and classic social science research had
showed the detrimental effects of blind obedience that such
gradients can create.[23–24] To illustrate, in a recent interviewwith
MDT members regarding the effectiveness of their meetings, 1
doctor reported: “I am always amazed how very able staff can be
so passive”[14]. Having an effectively trained leader and a
respectful team climate that balance out the authority gradients
and encourages inputs from all contributing members and
disciplines may help improve the decision-making process and
guard against potential team biases.
4.5. Generalizability
Although this is a large-scale study for its nature (based on in-vivo
observations), generalizability of our ﬁndings may be limited to
themost common cancerMDTswithin theNHS. Replication and
assessment of the generalizability of the current ﬁndings to other
cancerMDTs, in particular the lower-frequency cancers, needs to
be examined to determine the extent of which they apply to them.
5. Conclusion
As our results demonstrate for the ﬁrst time, MDT decisions in
most common cancers are driven by 4 underlying factors
encompassing all participating disciplines and a complete patient
proﬁle. It seems that all of these elements are necessary for the
collective decision-making ability of a team. We also demon-
strated a negative relationship between chairs’ inputs and their
corresponding disciplinary clinical input, possibly indicating
dual-task interference. Further research could proﬁtably investi-
gate how chairing and authority gradients affect team inter-
actions and contributions to case review inMDMswith a view to
improving service quality and group decision-making in a natural
context.
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